| 5CSZ: reference: Gantenerumab: a novel human anti-Abeta antibody demonstrates sustained cerebral amyloid-beta binding and elicits cell-mediated removal of human amyloid-beta., Bohrmann B, Baumann K, Benz J, Gerber F, Huber W, Knoflach F, Messer J, Oroszlan K, Rauchenberger R, Richter WF, Rothe C, Urban M, Bardroff M, Winter M, Nordstedt C, Loetscher H, J Alzheimers Dis. 2012;28(1):49-69. doi: 10.3233/JAD-2011-110977. PMID: 21955818 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).